Corcept Therapeutics Inc
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
WainwrightTheir analysis of patent portfolio indicated that Cort could prevail primarily due to the strength of the ‘214 patent..
|
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 2783 | Re: Wainwright - all about delay not who "wins" | i760 | 4 | 9/10/2019 11:54:10 AM |
